Lv et al.’s study on ainsliadimer A (AIN), which identified PRDX1 and PRDX2 as targets leading to ROS-mediated apoptosis in colorectal cancer cells, serves as a representative example of the power of combining multiple techniques [27]. Here, PRDX2 is linked to colorectal cancer.